Patents by Inventor Urjeet Khanwalkar

Urjeet Khanwalkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amplifiable RNAs for Therapeutic Cell Systems
    Publication number: 20220073875
    Abstract: This disclosure provides, among other things, amplifiable nucleic acid constructs for expressing a gene of interest in a cell, e.g., an erythroid cell. The amplifiable nucleic acid construct may contain the gene of interest and an RNA-dependent RNA polymerase (RdRP)-responsive 5? UTR, and may optionally further contain an RdRP-responsive 3? UTR. RdRP may also be provided, e.g., on the same construct or a different construct.
    Type: Application
    Filed: November 18, 2021
    Publication date: March 10, 2022
    Applicant: Rubius Therapeutics, Inc.
    Inventors: Qin Yu, Urjeet Khanwalkar, Omid Harandi, Ewan Dunn, Tanyaporn Pattarabanjird, Avak Kahvejian, Jordi Mata-Fink
  • AMPLIFIABLE RNAS FOR THERAPEUTIC CELL SYSTEMS
    Publication number: 20190330591
    Abstract: This disclosure provides, among other things, amplifiable nucleic acid constructs for expressing a gene of interest in a cell, e.g., an erythroid cell. The amplifiable nucleic acid construct may contain the gene of interest and an RNA-dependent RNA polymerase (RdRP)-responsive 5? UTR, and may optionally further contain an RdRP-responsive 3? UTR. RdRP may also be provided, e.g., on the same construct or a different construct.
    Type: Application
    Filed: January 10, 2019
    Publication date: October 31, 2019
    Inventors: Qin Yu, Urjeet Khanwalkar, Omid Harandi, Ewan Dunn, Tanyaporn Pattarabanjird, Avak Kahvejian, Jordi Mata-Fink
  • COMPOSITIONS AND METHODS RELATED TO THERAPEUTIC CELL SYSTEMS EXPRESSING EXOGENOUS RNA
    Publication number: 20190161730
    Abstract: The invention includes compositions and methods related to erythroid cells comprising exogenous RNA encoding a protein. The exogenous RNA can comprise a heterologous untranslated region comprising a regulatory element. Alternatively or in combination, the exogenous RNA can comprise chemical modifications.
    Type: Application
    Filed: July 7, 2017
    Publication date: May 30, 2019
    Inventors: Avak Kahvejian, Jordi Mata-Fink, Robert J. Deans, Omid Harandi, Urjeet Khanwalkar, Sneha Hariharan